{"id":"W1977715013","doi":"10.1016/j.purol.2010.11.010","title":"Traitement du carcinome rénal métastatique","year":2011,"lang":"fr","type":"review","venue":"Progrès en Urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Bevacizumab; Everolimus; Oncology; Renal cell carcinoma; Internal medicine; Population; Targeted therapy; Discovery and development of mTOR inhibitors; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00169218,0.001749124,0.003556106,0.0004350815,0.0001771805,0.00008822311,0.0009523497,0.001201458,0.004811343],"category_scores_gemma":[0.0005156959,0.001335778,0.001503608,0.0005091873,0.0005468549,0.0001612087,0.000539299,0.001807178,0.005934559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001855932,"about_ca_system_score_gemma":0.001743409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002631484,"about_ca_topic_score_gemma":0.0000210858,"domain_scores_codex":[0.9919665,0.001528089,0.001912734,0.001756472,0.0007356369,0.002100547],"domain_scores_gemma":[0.9956521,0.0008432736,0.0008233623,0.001440993,0.000313972,0.0009263447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002083877,0.001457935,0.009299657,0.01887381,0.001758725,0.003899562,0.0008448471,0.000004315377,0.000007576145,0.002429748,0.001368263,0.9598472],"study_design_scores_gemma":[0.001654094,0.005603763,0.01161116,0.003388937,0.007101947,0.001577089,0.00007125783,0.00003903716,0.00006034204,0.0002688566,0.9676282,0.0009952717],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002265508,0.9728718,0.0002191149,0.0011365,0.002243451,0.006024732,0.0001806421,0.0002875935,0.0147707],"genre_scores_gemma":[0.01628498,0.9694023,0.004667361,0.0005752118,0.002548883,0.002554532,0.0007378973,0.000274499,0.002954355],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.96626,"threshold_uncertainty_score":0.9995255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1062349129353821,"score_gpt":0.3317235450283949,"score_spread":0.2254886320930128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}